# Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients

> **NCT02269566** · PHASE1 · TERMINATED · sponsor: **Gachon University Gil Medical Center** · enrollment: 24 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** HollisterStier
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT02269566
- **Lead sponsor:** Gachon University Gil Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-08
- **Primary completion:** 2016-02
- **Final completion:** 2016-03
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** The number of enrolled subjects did not meet the goal during the study
- **Last updated:** 2016-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02269566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02269566, "Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02269566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*